HG-1423

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1423

Drug Alias NameRNASE6PL modulator (Human Genome Sciences)RNASET2 modulator (Human Genome Sciences)ribonuclease 6 precursor modulator (Human Genome Sciences)ribonuclease T2 modulator (Human Genome Sciences)FLJ10907 modulator (Human Genome Sciences) +[9]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionRibonucleases modulators

TargetsRibonucleases

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A